$2.02
0.021.00%
Pre-Market: 7:07 AM EDT
Comments
Loading...
NLS Pharmaceutics (NASDAQ:NLSP) Stock, Earnings Estimates, EPS, And Revenue
NLS Pharmaceutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 15
EPS
$-0.320
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of NLS Pharmaceutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
NLS Pharmaceutics (NLSP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-15 | $-0.32 | $ | -10000.0 % |
| Mar 2023 | 2023-05-05 | $-0.84 | $ | -10000.0 % |
| Sep 2022 | 2022-10-11 | $-0.54 | $ | -10000.0 % |
| Dec 2021 | 2022-03-24 | $-1.00 | $ | -10000.0 % |
NLS Pharmaceutics (NLSP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is NLS Pharmaceutics (NASDAQ:NLSP) reporting earnings?
NLS Pharmaceutics (NLSP) is scheduled to report earnings on December 31, 2024. The last reported earnings were for reported on May 15, 2024 for FY.
What were the latest earnings per share (EPS) for NLS Pharmaceutics (NASDAQ:NLSP)?
The Actual EPS was $-0.32, which missed the estimate of $0.00.
What were NLS Pharmaceutics’s (NASDAQ:NLSP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.